GEMCITABINE for Lung neoplasm malignant: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 534 adverse event reports in the FDA FAERS database where GEMCITABINE was used for Lung neoplasm malignant.
Most Reported Side Effects for GEMCITABINE
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Off label use | 3,319 | 10.6% | 496 | 1,162 |
| Disease progression | 3,123 | 10.0% | 558 | 411 |
| Thrombocytopenia | 2,320 | 7.4% | 271 | 875 |
| Drug ineffective | 2,003 | 6.4% | 486 | 431 |
| Malignant neoplasm progression | 1,962 | 6.3% | 602 | 411 |
| Neutropenia | 1,892 | 6.0% | 235 | 512 |
| Anaemia | 1,745 | 5.6% | 223 | 820 |
| Pyrexia | 1,511 | 4.8% | 148 | 1,102 |
| Nausea | 1,336 | 4.3% | 146 | 650 |
| Myelosuppression | 1,197 | 3.8% | 50 | 559 |
| Fatigue | 1,098 | 3.5% | 124 | 440 |
| Febrile neutropenia | 1,082 | 3.5% | 264 | 653 |
| Diarrhoea | 1,074 | 3.4% | 179 | 603 |
| Vomiting | 1,016 | 3.2% | 116 | 645 |
| Neoplasm progression | 960 | 3.1% | 239 | 175 |
Other Indications for GEMCITABINE
Pancreatic carcinoma (2,706)
Diffuse large b-cell lymphoma (2,506)
Product used for unknown indication (2,401)
Pancreatic carcinoma metastatic (1,586)
Cholangiocarcinoma (1,181)
Adenocarcinoma pancreas (1,089)
Bladder cancer (841)
Transitional cell carcinoma (825)
Ovarian cancer (648)
Non-small cell lung cancer (634)
Other Drugs Used for Lung neoplasm malignant
ERLOTINIB (9,207)
OSIMERTINIB (4,754)
NIVOLUMAB (4,197)
PEMBROLIZUMAB (3,575)
CARBOPLATIN (3,487)
ALECTINIB (2,932)
PEMETREXED (2,422)
CRIZOTINIB (1,949)
BEVACIZUMAB (1,810)
PACLITAXEL (1,747)